Sound Income Strategies LLC Has $114,000 Holdings in The Clorox Company (NYSE:CLX)

Sound Income Strategies LLC decreased its position in The Clorox Company (NYSE:CLX) by 9.9% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 697 shares of the company’s stock after selling 77 shares during the quarter. Sound Income Strategies LLC’s holdings in Clorox were worth $114,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. SG Americas Securities LLC boosted its position in Clorox by 1,525.7% during the 1st quarter. SG Americas Securities LLC now owns 65,612 shares of the company’s stock worth $10,046,000 after acquiring an additional 61,576 shares during the last quarter. Mizuho Markets Americas LLC grew its position in Clorox by 93.7% in the first quarter. Mizuho Markets Americas LLC now owns 72,053 shares of the company’s stock valued at $11,032,000 after purchasing an additional 34,864 shares in the last quarter. CANADA LIFE ASSURANCE Co lifted its position in Clorox by 15.2% during the 1st quarter. CANADA LIFE ASSURANCE Co now owns 141,622 shares of the company’s stock worth $21,705,000 after buying an additional 18,687 shares in the last quarter. Advisors Asset Management Inc. boosted its stake in shares of Clorox by 257.5% during the 1st quarter. Advisors Asset Management Inc. now owns 11,228 shares of the company’s stock worth $1,719,000 after buying an additional 8,087 shares during the last quarter. Finally, Game Plan Financial Advisors LLC acquired a new stake in shares of Clorox in the first quarter valued at about $1,025,000. 78.53% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Clorox

In other news, EVP Angela C. Hilt sold 1,733 shares of the stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the completion of the transaction, the executive vice president now owns 13,471 shares of the company’s stock, valued at approximately $2,229,719.92. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.51% of the company’s stock.

Analyst Ratings Changes

Several brokerages recently commented on CLX. Jefferies Financial Group raised Clorox from a “hold” rating to a “buy” rating and increased their price target for the company from $174.00 to $187.00 in a research report on Tuesday, October 1st. Evercore ISI dropped their target price on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a report on Monday. BNP Paribas upgraded Clorox to a “strong sell” rating in a research note on Friday, September 6th. Barclays boosted their price objective on Clorox from $130.00 to $137.00 and gave the stock an “underweight” rating in a report on Friday. Finally, Deutsche Bank Aktiengesellschaft increased their target price on Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a research note on Friday, August 2nd. Six research analysts have rated the stock with a sell rating, nine have assigned a hold rating and one has issued a buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $150.14.

Clorox Stock Up 0.8 %

CLX stock opened at $161.59 on Tuesday. The business has a 50-day simple moving average of $157.74 and a 200 day simple moving average of $144.78. The company has a market cap of $20.07 billion, a PE ratio of 83.73, a price-to-earnings-growth ratio of 3.19 and a beta of 0.41. The company has a quick ratio of 0.63, a current ratio of 1.03 and a debt-to-equity ratio of 5.04. The Clorox Company has a 52 week low of $114.68 and a 52 week high of $169.09.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Thursday, August 1st. The company reported $1.82 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.54 by $0.28. Clorox had a net margin of 3.95% and a return on equity of 281.12%. The business had revenue of $1.90 billion for the quarter, compared to analysts’ expectations of $1.97 billion. Sell-side analysts anticipate that The Clorox Company will post 6.64 EPS for the current fiscal year.

Clorox Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, November 7th. Investors of record on Wednesday, October 23rd will be paid a $1.22 dividend. This represents a $4.88 annualized dividend and a yield of 3.02%. The ex-dividend date of this dividend is Wednesday, October 23rd. Clorox’s dividend payout ratio (DPR) is presently 252.85%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.